• English
  • Korean
  • Chinese
表紙
市場調査レポート - 217230

糖尿病性腎症:世界の臨床試験レビュー(2011年下半期)

Diabetic Nephropathy Global Clinical Trials Review, H2, 2013

発行 GlobalData
出版日 ページ情報 英文 80 Pages
電子版即納可
価格
糖尿病性腎症:世界の臨床試験レビュー(2011年下半期) Diabetic Nephropathy Global Clinical Trials Review, H2, 2013
出版日: 2013年12月30日 ページ情報: 英文 80 Pages
概要

当レポートでは、糖尿病性腎症治療薬の臨床試験におけるデータを提供、国別の動向、臨床試験数、世界における臨床実験所別の募集状況などをまとめ、概略以下の構成でお届けします。

目次

イントロダクション

  • 糖尿病性腎症
  • 本レポートについて

地域別の臨床試験

  • 国別臨床試験
    • アジア太平洋における上位5か国
    • 欧州における上位5か国
    • 北米における上位国
    • 中東およびアフリカにおける上位5か国
    • 中南米における上位5か国

BRIC諸国における臨床試験

G7諸国における臨床試験

進捗状況別:G7諸国における臨床試験

E7諸国における臨床試験

進捗状況別:E7諸国における臨床試験

相別の臨床試験

進捗状況別の臨床試験

未達成の臨床試験

一定期間に採用された被験者

有望なスポンサー

有望な薬剤の比較

臨床試験プロファイル

  • 臨床試験概要:上位企業
    • Pfizer Inc
    • Eli Lilly and Company
    • Novartis AG
    • Abbott Laboratories
    • Keryx Biopharmaceuticals, Inc
    • FibroGen, Inc
    • Johnson & Johnson
    • Boehringer Ingelheim GmbH
    • Daiichi Sankyo Company, Ltd
    • Synvista Therapeutics, Inc
    • XTL Biopharmaceuticals Ltd
    • Reata Pharmaceuticals, Inc
    • BioStratum, Inc
    • Angelini Group
    • PhytoHealth Corporation
    • Sankyo Co, Ltd
    • MannKind Corporation
    • Vernalis plc
    • Bayer AG
    • NephroGenex, Inc
  • 臨床試験概要:上位大学・研究所・病院
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • Shanghai Jiao Tong University
    • Steno Diabetes Center A/S
    • Kanazawa Medical University
    • Okayama University
    • US Department of Veterans Affairs
    • Chinese University of Hong Kong
    • University of Washington
    • Nanjing Medical University
    • Shiraz University of Medical Sciences
    • Tehran University of Medical Sciences
    • Yokohama City University
    • Holstebro Hospital
    • The University of Texas Health Science Center at San Antonio
    • AHEPA University Hospital
    • Sheba Medical Center
    • Assaf-Harofeh Medical Center
    • Karolinska Institutet
    • Texas Tech University Health Sciences Center
    • Stanford University

主な臨床プロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Diabetic Nephropathy Global Clinical Trials Review, H2, 2013" provides data on the Diabetic Nephropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Nephropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Nephropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Diabetic Nephropathy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Diabetic Nephropathy
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Diabetic Nephropathy Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Steno Diabetes Center A/S
      • Clinical Trial Overview of Steno Diabetes Center A/S
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • IMMD Inc.
      • Clinical Trial Overview of IMMD Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • ChemoCentryx, Inc.
      • Clinical Trial Overview of ChemoCentryx, Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • GenKyoTex S.A.
      • Clinical Trial Overview of GenKyoTex S.A.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • Shanghai Jiao Tong University
      • Clinical Trial Overview of Shanghai Jiao Tong University
      • Joslin Diabetes Center
      • Clinical Trial Overview of Joslin Diabetes Center
      • Okayama University
      • Clinical Trial Overview of Okayama University
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Islamic Azad University of Tabriz
      • Clinical Trial Overview of Islamic Azad University of Tabriz
      • Shiraz University of Medical Sciences
      • Clinical Trial Overview of Shiraz University of Medical Sciences
      • Kanazawa Medical University
      • Clinical Trial Overview of Kanazawa Medical University
      • Holstebro Hospital
      • Clinical Trial Overview of Holstebro Hospital
      • Stanford University
      • Clinical Trial Overview of Stanford University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Zone, 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, North America, Top Countries, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, BRIC Countries, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, G7 Countries, 2013*
  • Diabetic Nephropathy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, E7 Countries, 2013*
  • Diabetic Nephropathy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Phase, 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Withdrawn Clinical Trials, 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Terminated Clinical Trials, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Steno Diabetes Center A/S, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by IMMD Inc., 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by ChemoCentryx, Inc., 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by GenKyoTex S.A., 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Joslin Diabetes Center, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa Medical University, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Holstebro Hospital, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2013*

List of Figures

  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, BRIC Countries (%), 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, G7 Countries (%), 2013*
  • Diabetic Nephropathy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, E7 Countries (%), 2013*
  • Diabetic Nephropathy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
  • Diabetic Nephropathy Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Diabetic Nephropathy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • GlobalData Methodology
Back to Top